What is YPrime?
Founded in 2006 and headquartered in Malverne, Pennsylvania, YPrime specializes in software solutions and consulting services designed to streamline clinical trial data collection and information management. The company serves biopharmaceutical firms and contract research organizations, facilitating more efficient and collaborative research processes. YPrime's offerings are critical for navigating the complexities of modern clinical trials, ensuring data integrity and accelerating drug development timelines.
How much funding has YPrime raised?
YPrime has raised a total of $18.6M across 6 funding rounds:
Private Equity
$5M
Private Equity
$2.5M
Private Equity
$2M
Debt
$5M
Private Equity
$2.1M
Debt
$2M
Private Equity (2013): $5M, investors not publicly disclosed
Private Equity (2014): $2.5M, investors not publicly disclosed
Private Equity (2016): $2M, investors not publicly disclosed
Debt (2016): $5M featuring Square 1 Bank
Private Equity (2017): $2.1M, investors not publicly disclosed
Debt (2020): $2M with participation from PPP
Key Investors in YPrime
Square 1 Bank
Square 1 Bank, now part of Banc of California, is a business bank offering tailored financial solutions, lending, and treasury management services to growing companies across various industries, including healthcare and technology.
What's next for YPrime?
With a history of consistent private equity and debt financing, YPrime appears to be in a growth and scaling phase, leveraging its enterprise-level capital to enhance its market presence. The recent strategic investment suggests a focus on expanding its technological capabilities and potentially broadening its service offerings to meet evolving industry demands. Future developments are likely to center on further integrating advanced data analytics and AI into its platform, solidifying its role as a key enabler of efficient clinical research.
See full YPrime company page
